Skip to main content

Advertisement

Log in

Comparison of epinephrine and felypressin pressure effects in 1K1C hypertensive rats treated or not with atenolol

  • Original Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Purpose

Epinephrine is considered the gold standard vasoconstrictor for hypertensive patients, but few studies report felypressin’s effects. The present study aimed to analyze and compare the effects of these two vasoconstrictors, injected by the intravenous route, on the arterial pressure of normotensive, hypertensive and atenolol-treated hypertensive rats.

Method

The hypertension model was one-kidney-one-clip (1K1C): the main left renal artery was partially constricted and the right kidney was surgically removed in 45-day-old male Wistar rats. 1K1C hypertensive rats received atenolol (90 mg/kg/day) by gavage for 2 weeks. 28–35 days after hypertension induction, a catheter was inserted into the left carotid artery to record direct blood pressure values. The following parameters were recorded: minimal hypotensive response, maximal hypertensive response, response duration and heart rate.

Results

Epinephrine, but not felypressin, exerted an important hypotensive action; non-treated hypertensive rats showed more pronounced vasodilation. Treated and non-treated rats showed hypertensive responses of the same magnitudes in all groups; 1K1C atenolol rats showed reduced hypertensive responses to both vasoconstrictors. Felypressin’s response duration was longer than that of epinephrine in all groups. Epinephrine increased heart rate while felypressin reduced this parameter only in the normotensive group.

Conclusions

Our results suggest that felypressin has equipotent pressure responses when compared with epinephrine, showing a greater extent of action. Atenolol’s reduction of hypertensive effects surprisingly suggests that atenolol β-blockade may also be important for felypressin’s cardiovascular effect, as is widely known for epinephrine. Our data suggest that felypressin is safe for hypertensive subjects, in particular those receiving atenolol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Salonen M, Forssell H, Scheinin M. Local dental anaesthesia with lidocaine and adrenaline. Effects on plasma catecholamines, heart rate and blood pressure. Int J Oral Maxillofac Surg. 1988;17:392–4.

    Article  CAS  PubMed  Google Scholar 

  2. Cecanho R, De Luca LA, Ranali J. Cardiovascular effects of felypressin. Anesth Prog. 2006;53:119–25.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Herman WW, Konzelman JL, Prisant LM, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. New national guidelines on hypertension: a summary for dentistry. J Am Dent Assoc. 2004;135:576–84 (quiz 653–574).

    Article  PubMed  Google Scholar 

  4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart L, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Committee NHBPEPC. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.

    Article  CAS  PubMed  Google Scholar 

  5. Glick M. New guidelines for prevention, detection, evaluation and treatment of high blood pressure. J Am Dent Assoc. 1998;129:1588–94.

    Article  CAS  PubMed  Google Scholar 

  6. Niwa H, Sato Y, Matsuura H. Safety of dental treatment in patients with previously diagnosed acute myocardial infarction or unstable angina pectoris. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:35–41.

    Article  CAS  PubMed  Google Scholar 

  7. Meechan JG, Parry G, Rattray DT, Thomason JM. Effects of dental local anaesthetics in cardiac transplant recipients. Br Dent J. 2002;192:161–3.

    Article  CAS  PubMed  Google Scholar 

  8. Nobre F, da Silva CA, Coelho EB, Salgado HC, Fazan R. Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2k1c rats. Am J Hypertens. 2006;19:1079–83.

    Article  CAS  PubMed  Google Scholar 

  9. Faria FA, Salgado MC. Facilitation of noradrenergic transmission by angiotensin in hypertensive rats. Hypertension. 1992;19:II30–5.

    Article  CAS  PubMed  Google Scholar 

  10. Covino BG. Systemic toxicity of local anesthetic agents. Anesth Analg. 1978;57:387–8.

    CAS  PubMed  Google Scholar 

  11. Yagiela JA. Local anesthetics: a century of progress. Anesth Prog. 1985;32:47–56.

    PubMed Central  CAS  PubMed  Google Scholar 

  12. Redfors B, Shao Y, Omerovic E. Influence of anesthetic agent, depth of anesthesia and body temperature on cardiovascular functional parameters in the rat. Lab Anim. 2014;48:6–14.

    Article  CAS  PubMed  Google Scholar 

  13. Adams HR, Parker JL, Mathew BP. The influence of ketamine on inotropic and chronotropic responsiveness of heart muscle. J Pharmacol Exp Ther. 1977;201:171–83.

    CAS  PubMed  Google Scholar 

  14. Hiley CR, Nichols AJ, Thomas GR. Interactions between noradrenaline and alpha 2-adrenoceptor agonists in the superior mesenteric arterial bed of the rat. Br J Pharmacol. 1986;89:779–85.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Meechan J, Cole B, Welbury R. The influence of two different dental local anaesthetic solutions on the haemodynamic responses of children undergoing restorative dentistry: a randomised, single-blind, split-mouth study. Br Dent J. 2001;190:502–4.

    CAS  PubMed  Google Scholar 

  16. Meechan J, Welbury R. Metabolic responses to oral surgery under local anesthesia and sedation with intravenous midazolam: the effects of two different local anesthetics. Anesth Prog. 1992;39:9–12.

    PubMed Central  CAS  PubMed  Google Scholar 

  17. Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2006;2:875–94.

    Article  CAS  PubMed  Google Scholar 

  18. Little JW. The impact on dentistry of recent advances in the management of hypertension. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:591–9.

    Article  CAS  PubMed  Google Scholar 

  19. Oliveira N, Gazola R, Singi G. Effects of vasoconstrictors used in local anesthesia upon isolated rat heart. Pharmacol Res. 2002;46:15–8.

    Article  CAS  PubMed  Google Scholar 

  20. Oliveira NS, Gazola R, Patez PS, Singi G. Effects of the prilocaine and of the association of prilocaine with different vasoconstrictors on the isolated hearts of rats. Pharmacol Res. 2003;48:325–8.

    Article  CAS  PubMed  Google Scholar 

  21. Bronzo AL, Cardoso CG, Ortega KC, Mion D. Felypressin increases blood pressure during dental procedures in hypertensive patients. Arq Bras Cardiol. 2012;99:724–31.

    Article  CAS  PubMed  Google Scholar 

  22. Yagiela JA. Adverse drug interactions in dental practice: interactions associated with vasoconstrictors. Part V of a series. J Am Dent Assoc. 1999;130:701–9.

    Article  CAS  PubMed  Google Scholar 

  23. Hersh EV, Giannakopoulos H. Beta-adrenergic blocking agents and dental vasoconstrictors. Dent Clin North Am. 2010;54:687–96.

    Article  PubMed  Google Scholar 

  24. Zhang C, Banting DW, Gelb AW, Hamilton JT. Effect of beta-adrenoreceptor blockade with nadolol on the duration of local anesthesia. J Am Dent Assoc. 1999;130:1773–80.

    Article  CAS  PubMed  Google Scholar 

  25. Kawano Y, Matsuoka H, Nishikimi T, Takishita S, Omae T. The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes. Am J Hypertens. 1997;10:1240–4.

    Article  CAS  PubMed  Google Scholar 

  26. Singi G, Oliveira NS, Araujo L, Singi M. Hemodynamic effects of felypressin and epinephrine on anesthetized rats. J Anesth. 2003;17:204–5.

    Article  PubMed  Google Scholar 

  27. Jackson E. Vasopressin and other agents affecting the renal conservation of water. Goodman and Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill, Inc.; 2006. p. 771–788.

  28. Bannay R, Böhm M, Husain A. Heart rate differentiates urgency and emergency in hypertensive crisis. Clin Res Cardiol. 2013;102:593–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dentsply Pharmaceutical (Catanduva, São Paulo, Brazil) for providing felypressin samples. Carlos F. Santos and Sandra L. Amaral received research grants from The São Paulo Research Foundation (FAPESP; grants # 2004/13479-3 and 2011/21522-0, respectively).

Conflict of interest

All the authors declare no conflict of interest. Pedro C. Lomba works at Dentsply Pharmaceutical Ltda.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlos F. Santos.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fleury, C.A., Andreo, V.C., Lomba, P.C. et al. Comparison of epinephrine and felypressin pressure effects in 1K1C hypertensive rats treated or not with atenolol. J Anesth 29, 56–64 (2015). https://doi.org/10.1007/s00540-014-1866-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-014-1866-y

Keywords

Navigation